CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Conditions
Diffuse Midline Glioma, H3 K27-Altered · Metastatic Malignant Neoplasm in the Central Nervous System · Recurrent Diffuse Intrinsic Pontine Glioma · Recurrent Diffuse Midline Glioma, H3 K27-Altered · Recurrent Lymphoma · Recurrent Malignant Solid Neoplasm · Recurrent Primary Malignant Central Nervous System Neoplasm · Refractory Lymphoma · Refractory Malignant Solid Neoplasm · Refractory Primary Malignant Central Nervous System Neoplasm
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Children's Hospital of Alabama, Birmingham, Alabama, United States
Contact: Principal Investigator (Girish Dhall)Phoenix Childrens Hospital, Phoenix, Arizona, United States
Contact: Principal Investigator (Alok K. Kothari)Children's Hospital Los Angeles, Los Angeles, California, United States
Contact: Principal Investigator (Fariba Navid)Children's Hospital of Orange County, Orange, California, United States
Contact: Principal Investigator (Josephine H. Haduong)UCSF Medical Center-Mission Bay, San Francisco, California, United States
Contact: Principal Investigator (Kieuhoa T. Vo)Children's Hospital Colorado, Aurora, Colorado, United States
Contact: Principal Investigator (Margaret E. Macy)Children's National Medical Center, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Site Public Contact) · OncCRC_OnCall@childrensnational.org · 202-476-2800Contact: Principal Investigator (AeRang Kim)Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
Contact: Principal Investigator (Jonathan L. Metts)Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States
Contact: Principal Investigator (Jason R. Fangusaro)Lurie Children's Hospital-Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Elizabeth A. Sokol)University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222Contact: Principal Investigator (Ami V. Desai)Riley Hospital for Children, Indianapolis, Indiana, United States
Contact: Principal Investigator (Brian D. Weiss)Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
Contact: Principal Investigator (Christine A. Pratilas)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Steven G. DuBois)C S Mott Children's Hospital, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Rajen Mody)University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Robin L. Williams)Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States
Contact: Principal Investigator (Kevin F. Ginn)Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Shalini Shenoy)Roswell Park Cancer Institute, Buffalo, New York, United States
Contact: Principal Investigator (Clare J. Twist)NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162Contact: Principal Investigator (Nobuko Hijiya)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Julia L. Glade Bender)New York Medical College, Valhalla, New York, United States
Contact: Principal Investigator (Mitchell S. Cairo)Duke University Medical Center, Durham, North Carolina, United States
Contact: Principal Investigator (Jessica M. Sun)Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Principal Investigator (Joseph G. Pressey)Oregon Health and Science University, Portland, Oregon, United States
Contact: Principal Investigator (Bill H. Chang)Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Theodore W. Laetsch)Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Andrew Bukowinski)Saint Jude Children's Research Hospital, Memphis, Tennessee, United States
Contact: Principal Investigator (Dana Tlais)UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States
Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097Contact: Principal Investigator (Laura J. Klesse)Cook Children's Medical Center, Fort Worth, Texas, United States
Contact: Study coordinator (Site Public Contact) · CookChildrensResearch@cookchildrens.org · 682-885-2103Contact: Principal Investigator (Sibo Zhao)Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Jennifer H. Foster)Primary Children's Hospital, Salt Lake City, Utah, United States
Contact: Principal Investigator (Matthew Dietz)Seattle Children's Hospital, Seattle, Washington, United States
Contact: Principal Investigator (Katherine G. Tarlock)Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Principal Investigator (Sarah Rumler)Sydney Children's Hospital, Randwick, New South Wales, Australia
Study leads
David S Ziegler
Principal Investigator
Pediatric Early Phase Clinical Trial Network